Pharmaceutical manufacturing industry is suffering from the operation of the new mechanism for drug price cut

On Mar 19, according to the pharmaceutical manufacturing industry, they are suffering from the operation of the new mechanism for drug price cut, followed by the existing regulatory policies.

First of all, the industry estimated annual savings of 60 billion won due to Price-volume agreement which is currently working. It is estimated that there are annual savings of 50~70 billion won due to dr...